INFECTIOUS COMPLICATIONS IN PATIENTS (PTS) WITH HEMATOLOGICAL MALIGNANCIES AND MATCHED UNRELATED DONOR (MUD) CD3 DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)

被引：0
|
作者：
MATTIUZZI, G [1 ]
VARTIVARIAN, S [1 ]
PRZEPIORKA, D [1 ]
GIRALT, S [1 ]
ABISAID, D [1 ]
CORTES, J [1 ]
CHAMPLIN, R [1 ]
ANAISSIE, E [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON CANC CTR,HOUSTON,TX 77025
来源：
BLOOD | 1994年 / 84卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A337 / A337
页数：1
相关论文
共 50 条
  • [21] EVALUATION OF BUSULFAN (BU)-BASED CONDITIONING REGIMENS PRIOR TO BONE-MARROW TRANSPLANTATION (BMT) IN PATIENTS (PTS) WITH LYMPHOID MALIGNANCIES
    NEVILL, TJ
    HAYNE, OA
    ANDERSON, DR
    FERNANDEZ, LA
    ING, VK
    ROBINSON, KS
    LANGLEY, GR
    BLOOD, 1994, 84 (10) : A716 - A716
  • [22] ALPHA/BETA T-CELL DEPLETED ALLOGENEIC STEM CELL TRANSPLANTATION FROM MATCHED RELATED AND UNRELATED DONOR GRAFTS IN PATIENTS WITH HIGH RISK HEMATOLOGICAL MALIGNANCIES
    De Witte, M. D.
    Fleurke, G.
    van de Wagen, L.
    Slaper, I.
    Kuball, J.
    HAEMATOLOGICA, 2015, 100 : 282 - 283
  • [23] PARTIALLY MATCHED RELATED DONOR (PMRD) ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) IN RECURRENT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    FLEMING, DR
    HENSLEEDOWNEY, PJ
    HARDER, EJ
    ROMOND, EH
    MESSINO, MJ
    MACDONALD, JS
    RAYENS, MK
    MARCINIAK, E
    BISHOP, M
    CIOCCI, G
    THOMPSON, JS
    FOON, KA
    BLOOD, 1994, 84 (10) : A214 - A214
  • [24] Alpha/Beta T- Cell Depleted Allogeneic Stem Cell Transplantation From Matched Related And Unrelated Donor Grafts In Patients With High Risk Hematological Malignancies
    De Witte, M. D.
    Fleurke, G.
    van de Wagen, L.
    Slaper, I.
    Kuball, J.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S472 - S472
  • [25] DIFFERENTIAL CD26-MEDIATED ACTIVATION OF THE CD3 AND CD2 PATHWAYS AFTER CD6-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION
    KAMEOKA, J
    SATO, T
    TORIMOTO, Y
    SUGITA, K
    SOIFFER, RJ
    SCHLOSSMAN, SF
    RITZ, J
    MORIMOTO, C
    BLOOD, 1995, 85 (04) : 1132 - 1137
  • [26] IMMUNOMODULATION RESULTING IN COMPLETE REMISSION IN PATIENTS (PTS) WITH RESIDUAL OR RELAPSED MALIGNANCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
    COLLINS, R
    PINEIRO, L
    LANIER, A
    FAY, J
    BLOOD, 1993, 82 (10) : A417 - A417
  • [27] Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft
    C-K Lee
    M deMagalhaes-Silverman
    R J Hohl
    M Hayashi
    J Buatti
    B-C Wen
    A Schlueter
    R G Strauss
    R D Gingrich
    Bone Marrow Transplantation, 2003, 31 : 121 - 128
  • [28] Relationship of tacrolimus blood levels to efficacy and safety outcomes after allogeneic bone marrow transplantation using a matched unrelated donor (MUD)
    Iguchi, T
    Mori, T
    Watanabe, R
    Aisa, Y
    Shimizu, T
    Tsukada, Y
    Ikeda, Y
    Okamoto, S
    BONE MARROW TRANSPLANTATION, 2003, 31 : S140 - S140
  • [29] Late-onset non-infectious pulmonary complications after bone marrow transplantation from matched unrelated donor
    Skert, C
    Patriarca, F
    Prosdocimo, S
    Fili, C
    Sperotto, A
    Geromin, A
    Cerno, M
    Fanin, R
    BONE MARROW TRANSPLANTATION, 2003, 31 : S140 - S141
  • [30] CD8+T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens
    Kalaycio, M
    Rybicki, L
    Pohlman, B
    Sobecks, R
    Ball, E
    Cook, D
    Andresen, S
    Kuczkowski, E
    Bolwell, B
    BONE MARROW TRANSPLANTATION, 2005, 35 (03) : 247 - 252
12345